Muscle-targeted extracellular vesicles for full-length dystrophin mRNA therapy in Duchenne muscular dystrophy - PubMed
4 hours ago
- #Duchenne muscular dystrophy
- #extracellular vesicles
- #dystrophin mRNA therapy
- The article focuses on muscle-targeted extracellular vesicles for delivering full-length dystrophin mRNA therapy.
- It discusses a therapeutic approach for Duchenne muscular dystrophy.
- The author declares no competing interests.
- References include works on Duchenne muscular dystrophy, Ann. Med. Surg., and Drugs Today.
- Full-length dystrophin mRNA is delivered using extracellular vesicles for targeted muscle treatment.